ZAZZERONI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 3.589
EU - Europa 2.669
AS - Asia 1.047
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 7
SA - Sud America 4
AF - Africa 1
Totale 7.327
Nazione #
US - Stati Uniti d'America 3.577
IE - Irlanda 810
CN - Cina 563
TR - Turchia 423
IT - Italia 386
SE - Svezia 384
DE - Germania 280
GB - Regno Unito 219
FR - Francia 207
UA - Ucraina 204
FI - Finlandia 108
BE - Belgio 30
VN - Vietnam 29
IN - India 15
EU - Europa 10
NL - Olanda 9
RU - Federazione Russa 5
AT - Austria 4
AU - Australia 4
CA - Canada 4
KR - Corea 4
PT - Portogallo 4
BR - Brasile 3
CH - Svizzera 3
JP - Giappone 3
MX - Messico 3
NZ - Nuova Zelanda 3
ES - Italia 2
IR - Iran 2
LT - Lituania 2
MY - Malesia 2
PA - Panama 2
PL - Polonia 2
RS - Serbia 2
BN - Brunei Darussalam 1
BO - Bolivia 1
BT - Bhutan 1
BZ - Belize 1
CR - Costa Rica 1
DK - Danimarca 1
GR - Grecia 1
HK - Hong Kong 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
MA - Marocco 1
MK - Macedonia 1
NO - Norvegia 1
PK - Pakistan 1
PR - Porto Rico 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
Totale 7.327
Città #
Chandler 864
Jacksonville 819
Dublin 804
Izmir 191
Boardman 163
Nanjing 159
San Mateo 135
Wilmington 117
Lawrence 114
Princeton 114
Ann Arbor 105
New York 86
L'aquila 78
Ashburn 74
Beijing 62
Nanchang 60
Bremen 59
Woodbridge 53
Aquila 48
Milan 47
Shenyang 44
L’Aquila 40
Verona 34
Mountain View 33
Brussels 30
Dong Ket 28
Jiaxing 28
Seattle 28
Hebei 27
Los Angeles 27
Tianjin 27
Des Moines 22
Kunming 21
Zhengzhou 20
Changsha 18
Dearborn 17
Ningbo 16
Helsinki 14
Jinan 13
Shanghai 13
Norwalk 12
Redmond 9
Edinburgh 8
Guangzhou 8
Houston 8
Taizhou 8
Auburn Hills 7
Changchun 7
Hangzhou 7
Lissone 7
Falls Church 5
Fremont 5
Pescara 5
Philadelphia 5
Redwood City 5
Rome 5
Caserta 4
Delhi 4
Düsseldorf 4
Hefei 4
Lanzhou 4
Pune 4
Vienna 4
Washington 4
Absecon 3
Acerra 3
Bergamo 3
Cedar Knolls 3
Collarmele 3
Fairfield 3
Frankfurt am Main 3
Iksan 3
Pittsburgh 3
Tappahannock 3
Amsterdam 2
Andover 2
Auckland 2
Castelletto 2
Centrale 2
Chicago 2
Cugnoli 2
Dallas 2
Foggia 2
Haikou 2
Hanover 2
Leamington Spa 2
Lisbon 2
London 2
Orange 2
Palermo 2
Panama City 2
Recale 2
Rho 2
Saint-Fons 2
Simi Valley 2
Torino 2
Toronto 2
Venezia 2
Vilnius 2
Angra dos Reis 1
Totale 4.876
Nome #
new bioinformatics approach to identify target genes for dysregulated micrornas in a chemically-induced hepatocarcinoma mouse model 117
Bioinformatics approach to predict target genes for dysregulated microRNAs in hepatocellular carcinoma: Study on a chemically-induced HCC mouse model 111
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 109
Combined antiviral therapy reduces HIV-1 plasma load and improves CD4 counts but does not intefere with ongoing lymphocytes apoptosis 103
Cancer secretome and inflammation: The bright and the dark sides of NF-kB 101
Ruolo del gene oncosoppressore KCTD11REN(KCTD11) nel carcinoma prostatico umano. 96
Therapeutic Use of MicroRNAs in Cancer 96
ANALISI DEL miRNoma NELL’EPATOCARCINOMA INDOTTO DA DIETILNITROSAMINA 93
EFFECTS OF SAFFRON ON HEPATOCARCINOGENESIS PROCESS: A STUDY ON A MOUSE MODEL 92
KRAS and Two Rare PI3KCA Mutations Coexisting in a Metastatic Colorectal Cancer Patient With Aggressive and Resistant Disease. 91
Adipose-derived stem cells sustain prolonged angiogenesis through leptin secretion 87
Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach? 86
MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice 86
Development of hepatocellular cancer induced by long term low fat-high carbohydrate diet in a nafld/nash mouse model 84
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 83
The N-terminal domain of the bone protein PRoline/arginine-rich End Leucine-rich repeat Protein (PRELP) impairs osteoclast formation by a new mechanism inhibiting NF-kappaB signaling 81
Next-generation sequencing: Recent applications to the analysis of colorectal cancer 81
The Role of Circulating MicroRNAs as Biomarkers in NAFLD 81
GADD45β loss ablates innate immunosuppression in cancer 80
MIRNOME ANALYSIS IN THE PATHOGENESIS OF HEPATOCARCINOMA 79
Analisi del miRNoma nell’epatocarcinogenesi indotta da dietilnotrosamina. 78
The tetrahydroisoquinoline derivative SB269,652 is an allosteric antagonist at dopamine D3 and D2 receptors. 77
Gadd45 beta mediates the NF-kappa B suppression of JNK signalling by targeting MKK7/JNKK2 77
Regolazione trascrizionale ed epigenetica del gene oncosoppressore KCTD11REN. 77
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 75
Apoptosis or programmed cell death 75
A method for isolating prosurvival targets of NF-kappaB/Rel transcription factors 75
UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) AND METALLOPROTEINASE (MMP-9) PRODUCTION IS IN-CREASED IN SHORT TERM CULTURES OF HUMAN PROSTATIC CARCINOMA. 75
development of hepatocellular cancer in a murine model of nonalcoholic steatohepatitis induced by use of low-fat/high carbohydrate diet 75
JNK: a killer on a transcriptional leash 74
A KRAS and dual concomitant PI3KCA mutations in a metastatic colorectal cancer patient with aggressive and resistant disease 74
mir-182 dysregulation in a diet-induced NAFLD-NASH-hepatocellular carcinoma mouse model 74
Acetyl-L-carnitine administration increases insulin-like growth factor 1 levels in asymptomatic HIV-1-infected subjects: correlation with its suppressive effect on lymphocyte apoptosis and ceramide generation 73
two simulteneous and very uncommom pi3kca mutations in a liver metastasis from colorectal cancer patient with aggressive and resistant disease 73
Cell signalling (communication arising) - Cell survival and a Gadd45-factor deficiency - Reply 73
Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma 71
The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity 71
The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis 69
Serum biomarkers identification by mass spectrometry in high-mortality tumors. 69
crosstalk between nf-kb and shh pathways in prostate cancer 69
Analisi del miRNoma nell’epatocarcinogenesi indotta da dietilnotrosamina. 68
Effect of L-carnitine treatment in vivo on apoptosis and ceramide generation in peripheral blood lymphocytes from AIDS patients 68
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 67
MicroRNAs in the DNA Damage/Repair Network and Cancer 66
Turning an old GADDget into a troublemaker 66
Upregulation of Twist-1 by NF-{kappa}B Blocks Cytotoxicity Induced by Chemotherapeutic Drugs 65
Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling 65
Identification of Novel Factors that Block Programmed Cell Death or Apoptosis by Targeting JNK 65
2-Aminopurine unravels a role for pRB in the regulation of gene expression by transforming growth factor beta 64
Induction of gadd45 beta by NF-kappa B down-regulates pro-apoptotic JNK signaling 64
Biotech on the Rise: The Treatment of Psoriasis with Biological Drugs 64
The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering 64
Improved tissue culture method for the study of prostatic carcinoma: a significant diagnostic tool 63
The NF-kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease 63
KCTD11 tumor suppressor gene expression is reduced in prostate adenocarcinoma 63
Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species 62
Effect of L-carnitine on human immunodeficiency virus-1 infection-associated apoptosis: a pilot study 62
The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages. 62
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 62
Reverse-phase protein microarray highlights HER2 signaling activation in immunohistochemistry/FISH/HER2-negative breast cancers. 62
EGF regulates a complex pattern of gene expression and represses smooth muscle differentiation during the neurotypic conversion of the neural-crest-derived TC-1S cell line 61
Combined antiviral therapy reduces HIV-1 plasma load and improves CD4 counts but does not interfere with ongoing lymphocyte apoptosis 61
Characterization and biologic role of REN, a novel gene involved in neural cell differentiation 61
Pro-angiogenic potential of adipose derived mesenchimal stem cells (AD-MSCs) in hypoxic condition 61
the role of kctd11 tumor suppressor gene in prostate cancer 61
Regulation of the gadd45beta promoter by NF-kappaB 59
Effect of l-carnitine treatment in vivo on apoptosis and ceramide generation in peripheral blood lymphocytes from aids patients: correlation with in vitro results 59
MiRNome analysis in high-fat diet-induced hepatocarcinoma. 59
Effect of L-carnitine treatment in vivo on apoptosis and ceramide generation by peripheral blood lymphocytes from AIDS patients. 58
Possibile anti-apoptotic activity of carnitines on excitatory amino acid induced neurotoxicity 58
FINASTERIDE REDUCES GROWTH RATE OF HUMAN PROSTATIC CARCINOMA IN VITRO 57
Combination therapy with cyclosporine and methotrexate in patients with early rheumatoid arthritis soon inhibits TNFalpha production without decreasing TNFalpha mRNA levels. An in vivo and in vitro study 57
The tumor suppressor gene KCTD11 REN is regulated by SP1 and methylation and its expression is reduced in tumors 56
REN: a novel, developmentally regulated gene that promotes neural cell differentiation 56
IMMUNOHISTOCHEMICAL EVALUATION OF WILD-TYPE AND MUTANT P-53 PROTEIN IN HUMAN PROSTA-TIC CANCER IN PRIMARY CULTURE 55
Targeting costimulatory molecules to improve antitumor immunity. 55
Oxygen JNKies: phosphatases overdose on ROS 55
The NF-kappaB-mediated control of ROS and JNK signaling 55
NF-kappaB meets ROS: an 'iron-ic' encounter 54
The N-terminal domain of the bone protein PRoline/arginine-rich End Leucine-rich repeat Protein (PRELP) impairs osteoclast formation by a new mechanism inhibiting NF-kappaB signaling 54
Inhibition of ErbB receptors, Hedgehog and NF-kappaB signaling by polyphenols in cancer. 54
Reprogramming Tumor-Immune Cell Interface in Solid and Hematological Malignancies to Enhance Response to Therapy 54
REN(KCTD11) is a suppressor of Hedgehog signaling and is deleted in human medulloblastoma 53
Basal cell carcinoma and inflammation: role of the Gadd45b gene 53
Mechanisms of liver disease: cross-talk between the NF-kappaB and JNK pathways 52
NF-kappaB and JNK: An Intricate Affair 52
Different apoptotic pathways activated by daunorubicin in human lymphocytes and fibroblasts 52
Biotechnological approaches for the treatment of inflammatory diseases 52
Gadd45beta promotes hepatocyte survival during liver regeneration in mice by modulating JNK signaling 50
NF-kappaB protects from the lysosomal pathway of cell death 49
In the Crosshairs: NF-κB Targets the JNK Signaling Cascade. 49
Emerging role of isomirs in cancer: State of the art and recent advances 49
Gadd45 beta mediates the protective effects of CD40 costimulation against Fas-induced apoptosis 48
Effect of L-Carnitine on Fas-induced apoptosis and sphingomyelinase activity in human T cell lines. 48
Identification of Novel Factors that Block Programmed Cell Death or Apoptosis by Targeting JNK 48
Human pituitary tumours express the bHLH transcription factors NeuroD1 and ASH1 46
Induction of a cathepsin B inhibitor by NF-kB blocks the lysosomal pathway of cell death 46
Linking JNK signaling to NF-kappaB: a key to survival 45
Nifedipine stimulates endothelial progenitor cell migratory ability by reducing intracellular oxidative stress 45
Concurrent RAS and RAS/BRAF V600E variants in colorectal cancer: more frequent than expected? 45
Totale 6.738
Categoria #
all - tutte 25.935
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.935


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019307 0 0 0 0 0 0 0 0 0 0 26 281
2019/2020964 216 13 133 11 6 124 180 6 127 21 8 119
2020/20211.018 55 112 5 111 120 43 148 20 107 47 182 68
2021/2022754 46 65 159 64 49 6 12 50 47 23 50 183
2022/20232.456 148 156 35 304 266 253 6 133 1.021 13 84 37
2023/2024497 72 26 31 91 35 133 18 64 4 23 0 0
Totale 7.520